<DOC>
	<DOCNO>NCT01479374</DOCNO>
	<brief_summary>The purpose study assess safety efficacy AL-4943A ophthalmic solution treatment ocular itching associate allergic conjunctivitis use Conjunctival Allergen Challenge ( CAC ) model .</brief_summary>
	<brief_title>Efficacy Safety AL-4943A Ophthalmic Solution Patients With Allergic Conjunctivitis Using Conjunctival Allergen Challenge ( CAC ) Model</brief_title>
	<detailed_description>This study consist 5 Visits . Eligible patient underwent allergy test use Conjunctival Allergen Challenge ( CAC ) model , reproduce sign symptom Seasonal Allergic Conjunctivitis replicate natural disease process . Patients demonstrate positive reaction CAC Visit 1 ( screen ) Visit 2 ( confirmatory ) randomize treatment Visit 3 ( Day 0 ) . The test article instill Visit 3 , treatment efficacy CAC perform 24 hour duration action . The test article instill Visit 4 ( Day 14 ) , treatment efficacy CAC perform 16 hour duration action . The test article instill final time Visit 5 ( Day 21 ) , treatment efficacy perform onset action .</detailed_description>
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Able dosed eye , able willing make require study visit follow instruction . Diagnostic skin test indicative allergy cat hair , cat dander , grass , ragweed , dust mite , dog dander , cockroach and/or tree within 24 month Visit 1 . History seasonal perennial allergic conjunctivitis least 1 year prior Visit 1 . Positive bilateral CAC response Visit 1 Visit 2 . Willing discontinue contact lens wear least 72 hour prior Visit 1 throughout study . Other protocoldefined inclusion criterion may apply . Known history presence persistent dry eye syndrome , currently require frequent use ( &gt; 4 day per week ) artificial tear , gel lubricant , presence punctal plug , use RestasisÂ® , topical ocular corticosteroid dryness eye . Presence active blepharitis , active meibomian gland dysfunction , active rosacea affect ocular adnexa , follicular conjunctivitis , iritis , preauricular lymphadenopathy , ocular irritation due ocular allergy , clinically significant ophthalmic abnormality may affect study outcome . Presumed actual ocular infection ( bacterial , viral fungal ) history ocular herpes either eye determine patient history and/or examination within 30 day Visit 1 . Presence chronic ocular degenerative condition active intraocular inflammation either eye opinion Investigator likely advance/worsen time course study . Any contraindication hypersensitivity use study medication component . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Allergic Conjunctivitis</keyword>
	<keyword>Ocular Allergy</keyword>
</DOC>